Skip to main content
. 2018 Jan 5;9(11):9885–9906. doi: 10.18632/oncotarget.24009

Table 2. Cytocidal activities of B2RAs and standard chemotherapeutic agents against MDA-MB-231 cells.

Agents IC50 values
HOE 140 > 100 μM
FR173657 20 ± 1 μM
NG68 45 ± 1 μM
NG134 > 100 μM
BCNU (carmustine) 62 ± 1 μM
Adriamycin (doxorubicin) 2 ± 1 μM
Carboplatin > 100 μM
Temozolomide (Temodar) > 100 μM
Paclitaxel (Taxol) 10 ± 1 μM

Data represent means ± s.e.m. (n = 6 to 8 experiments). Cell viability was established by the MTT assay after 72h drug exposure. IC50 values were calculated from complete concentration response-curve from no response to 80–100% cell death.